Skip to content
← All settings

DISEASE & TREATMENT SETTING

Penile Cancer

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Penile Cancer

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      unresolved
      derivation note
      Derived from NCI topic(s): Penile Cancer. Strongest NCIt resolution: ambiguous. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
      source wording
      Source null
      6 more-specific settings

      Study evidence for this setting

      13 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00512096 · Registry condition search · Scope: narrower

      Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis

      1 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00955929 · Registry condition search · Scope: narrower

      Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

      4 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT01209325 · Registry condition search · Scope: narrower

      Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01585428 · Registry condition search · Scope: narrower

      Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

      2 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02280811 · Registry condition search · Scope: narrower

      T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

      6 outcome links · 6 safety-group records · 0 quality-of-life measures

      →

      NCT02721732 · Registry condition search · Scope: narrower

      Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT02837042 · Registry condition search · Scope: narrower

      Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03260023 · Registry condition search · Scope: narrower

      Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

      6 outcome links · 7 safety-group records · 0 quality-of-life measures

      →

      NCT03427411 · Registry condition search · Scope: narrower

      M7824 in Subjects With HPV Associated Malignancies

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT03439085 · Registry condition search · Scope: narrower

      DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated C

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03856437 · Registry condition search · Scope: narrower

      A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination

      3 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT04231981 · Registry condition search · Scope: narrower

      Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT05959564 · Registry condition search · Scope: narrower

      A Chatbot Intervention for Reducing HPV Vaccine Hesitancy

      3 outcome links · 3 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-penile-cancer
        binding id
        ncit-C118820
        source collection
        ncit-concept
        source key
        C118820
        source excerpt
        Source null
        match status
        ambiguous
        match note
        Resolution status: ambiguous.
        recorded at
        2026-09-10T00:00:00Z
      2. release id
        clinical-indications-draft-1
        disease state id
        ds-penile-cancer
        binding id
        ncit-C9061
        source collection
        ncit-concept
        source key
        C9061
        source excerpt
        Source null
        match status
        ambiguous
        match note
        Resolution status: ambiguous.
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice